RCUS Arcus Biosciences, Inc.
Arcus Biosciences, Inc. (RCUS) Institutional Ownership
What the institutions did with RCUS last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| GILEAD SCIENCES, INC. | 31.4M | 25.7% |
| BlackRock, Inc. | 16.4M | 13.4% |
| STATE STREET CORP | 6.0M | 4.9% |
| WELLINGTON MANAGEMENT GROUP LLP | 5.9M | 4.8% |
| MONTANOVA CAPITAL, LLC | 4.8M | 3.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.5M | 3.7% |
| FMR LLC | 4.0M | 3.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9M | 3.2% |
| CITADEL ADVISORS LLC | 3.1M | 2.6% |
| Woodline Partners LP | 3.0M | 2.5% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4M | 2.0% |
| Siren, L.L.C. | 2.4M | 2.0% |
| Fisher Asset Management, LLC | 2.1M | 1.7% |
| MARSHALL WACE, LLP | 1.9M | 1.6% |
| SAMLYN CAPITAL, LLC | 1.5M | 1.3% |
| DIMENSIONAL FUND ADVISORS LP | 1.4M | 1.2% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.4M | 1.2% |
| GOLDMAN SACHS GROUP INC | 1.4M | 1.1% |
| Soleus Capital Management, L.P. | 1.2M | 1.0% |
| Sofinnova Investments, Inc. | 945.7K | 0.8% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 941.8K | 0.8% |
| NORTHERN TRUST CORP | 932.5K | 0.8% |
| Parkman Healthcare Partners LLC | 919.3K | 0.8% |
| Invesco Ltd. | 845.2K | 0.7% |
| BAKER BROS. ADVISORS LP | 844.8K | 0.7% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| FMR LLC | Increased | 1.2M | 4.0M | +2.9M |
| MARSHALL WACE, LLP | Reduced | 3.8M | 1.9M | -1.8M |
| CITADEL ADVISORS LLC | Increased | 1.3M | 3.1M | +1.8M |
| BlackRock, Inc. | Increased | 15.2M | 16.4M | +1.2M |
| Trails Edge Capital Partners, LP | Sold Out | 1.0M | 0 | -1.0M |
| Woodline Partners LP | Reduced | 3.8M | 3.0M | -770.0K |
| Soleus Capital Management, L.P. | Increased | 452.0K | 1.2M | +716.8K |
| STATE STREET CORP | Increased | 5.4M | 6.0M | +616.6K |
| T. Rowe Price Investment Management, Inc. | New | 0 | 589.5K | +589.5K |
| Siren, L.L.C. | Reduced | 3.0M | 2.4M | -586.6K |
| Logos Global Management LP | Reduced | 1.2M | 650.0K | -550.0K |
| Ikarian Capital, LLC | New | 0 | 504.6K | +504.6K |
| BAKER BROS. ADVISORS LP | Increased | 415.6K | 844.8K | +429.2K |
| RENAISSANCE TECHNOLOGIES LLC | Sold Out | 424.7K | 0 | -424.7K |
| GOLDMAN SACHS GROUP INC | Increased | 999.8K | 1.4M | +387.8K |
| SAMLYN CAPITAL, LLC | Reduced | 1.9M | 1.5M | -361.2K |
| JPMORGAN CHASE & CO | Increased | 80.8K | 418.2K | +337.4K |
| TWO SIGMA INVESTMENTS, LP | Increased | 312.7K | 635.4K | +322.7K |
| MORGAN STANLEY | Reduced | 1.1M | 795.9K | -317.6K |
| Parkman Healthcare Partners LLC | Reduced | 1.2M | 919.3K | -288.0K |
| FIRST TRUST ADVISORS LP | Increased | 13.1K | 271.4K | +258.3K |
| MONTANOVA CAPITAL, LLC | Reduced | 5.0M | 4.8M | -254.6K |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | Reduced | 1.7M | 1.4M | -235.2K |
| BNP PARIBAS FINANCIAL MARKETS | Reduced | 381.9K | 153.1K | -228.7K |
| Hudson Bay Capital Management LP | Reduced | 356.5K | 140.0K | -216.5K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.